<DOC>
	<DOCNO>NCT00007423</DOCNO>
	<brief_summary>The purpose study see safe give ALVAC-HIV vCP205 , possible HIV vaccine , study immune response adult HIV-1 uninfected volunteer . Uganda severely affect HIV infection AIDS select participate HIV-vaccine development . The HIV viruses commonly isolated Uganda 2 kind use make current vaccine . Current vaccine generate several kind immune response . Researchers would like see response kind virus current vaccine also protect people virus commonly find Uganda .</brief_summary>
	<brief_title>Safety Effectiveness Vaccine ALVAC-HIV vCP205 HIV-Negative Adult Volunteers Uganda</brief_title>
	<detailed_description>The African country Uganda severely affect HIV infection AIDS select World Health Organization participate HIV-vaccine development . The predominant HIV-1 strain isolate Ugandans member clade A clade D. The vaccine available human test base envelope proteins clade B clade E virus . ALVAC-HIV vCP205 second generation vaccine induce humoral cellular response several antigen . The current study attempt extend finding determine vCP205 vaccine , administer Ugandans , induce cytotoxic T-lymphocyte ( CTL ) responses reactive HIV strain prevalent Uganda . Volunteers randomize 1 3 group receive either candidate HIV-1 vaccine ALVAC-HIV vCP205 , experimental canarypox rabies vaccine ALVAC-RG , placebo-ALVAC . Neither volunteer his/her health care professional know preparation give . Volunteers receive 4 injection period 6 month follow 24 month . Clinical observation monitor hematological , chemical , immunologic parameter do . Safety evaluate monitor local systemic adverse reaction course trial . Comparative immunogenicity analysis base CTL response HIV measure bind HIV-specific antibody response . At visit , volunteer counsel avoid HIV exposure pregnancy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Inclusion Criteria Volunteers may eligible study : Are 18 40 year age . Have negative pregnancy test time entry agree use birth control 1 month prior first injection active followup . Have normal history physical examination . Are negative Hepatitis B . Are HIVnegative . Have blood cell infect EpsteinBarr virus . Are available followup study ( 24 month ) . Exclusion Criteria Volunteers eligible study : Have sexually transmit disease 1 sex partner previous 12 month . Are pregnant breastfeeding . Have immune disease , chronic illness , malignancy . Persons cancer surgically remove think cure eligible . Have use medication affect immune system . Have medical mental condition job may interfere study . Have receive certain live vaccine within 60 day study . Other vaccine flu pneumococcal exclude receive least 2 week away HIV immunization . Have use experimental agent within 30 day prior study . Have receive blood product within last 6 month . Have syphilis . Have HIVpositive partner . Have tuberculosis . Have currently severe allergic reaction vaccine , egg neomycin , substance . require hospitalization medical care . Have immunize treated rabies within 6 month receive injection . Are poultry worker . Have malaria treat respond treatment . Have schistosomiasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>HIV Antibodies</keyword>
	<keyword>HIV-1</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Uganda</keyword>
	<keyword>Cross Reactions</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>